decreased circulating glucose level_Nmur2<tm1Dgen>/Nmur2<tm1Dgen>

http://metadb.riken.jp/0005560B6NCgNmur2tm1DgenNmur2tm1DgenNmur2tm1DgenNmur2tm1Dgen

decreased circulating glucose level_Nmur2<tm1Dgen>/Nmur2<tm1Dgen>

表現型アノテーション

MGI marker

http://metadb.riken.jp/db/mgi_rdf/variant_of

• neuromedin U receptor 2
  http://metadb.riken.jp/db/mgi_rdf/MGI:2441765

遺伝子型

http://metadb.riken.jp/db/mgi_rdf/allele_composition

• Nmur2<tm1Dgen>/Nmur2<tm1Dgen>

アレルシンボル

http://metadb.riken.jp/db/mgi_rdf/allele_symbol

• Nmur2<tm1Dgen>

遺伝的背景

http://metadb.riken.jp/db/mgi_rdf/genetic_background

• B6N.Cg-Nmur2<tm1Dgen>

MP annotation

http://metadb.riken.jp/db/bioresource_schema/brs_indicatesPhenotype

• decreased circulating glucose level
  http://purl.obolibrary.org/obo/MP_0005560

文献

http://purl.org/net/cito/citesAsAuthority

• Andrea. Peier, et.al., The antiobesity effects of centrally administered neuromedin U and neuromedin S are mediated predominantly by the neuromedin U receptor 2 (NMUR2)., Endocrinology, 2009, 150
  http://rdf.ncbi.nlm.nih.gov/pubmed/19324999